Post-Marketing Surveillance of TISSUCOL for Hemostasis in Subjects Undergoing Vascular Reconstruction With Polytetrafluoroethylene (PTFE) Prosthesis

This study investigates if the time to hemostasis can be reduced by application of Tissucol® onto femoral vascular anastomoses with PTFE prostheses compared to standard methods, such as compression with swabs.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Femoral Vascular Anastomosis

Sex eligibility

All sexes

Study type

Observational

Primary location

General Hospital (AKH) Salzburg, Salzburg, State of Salzburg, Austria

Who can participate

Only the study team can determine whether someone qualifies for participation.

Subjects with femoral vascular anastomosis and bleeding suture holes after vessel reconstruction with a PTFE prosthesis

Treatment and study plan

Tissucol®

Drug

Control: Conventional treatment, i.e. compression with swabs

Procedure

Sponsors and collaborators

Lead sponsor

Baxter Healthcare Corporation

Industry

Registry information

Official study title

Non- Interventional Study of Tissucol® for Hemostasis in Subjects With Femoral Vascular Anastomosis Undergoing Vascular Reconstruction With PTFE Prosthesis

Important dates

Study start: 2003
Study completion: 2004
First posted: Sep 14, 2005
Registry last updated: Oct 23, 2006

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.